As we enter the new year, CIRM’s 2017 Annual Report will be posted in a few short weeks! Here’s a sneak peek at CIRM’s progress in clinical trials. At the start of 2017, we set a goal of finding and funding 12 new, high quality clinical trials. We easily beat that goal, funding 16, in … Continue reading Accelerating stem cell treatments to patients in 2017
clinical trials
Budget for CIRM’s Future
The CIRM Board discusses the future of the Stem Cell Agency Last week the California Institute for Regenerative Medicine's looked at what the stem cell agency has in the back, and set out a plan to budget for CIRM's future. Last year CIRM spent about $306 million on a wide range of research. That leaves … Continue reading Budget for CIRM’s Future
Stem Cell Stories That Caught our Eye: Stem Cell Therapies for Stroke and Duchenne Muscular Dystrophy Patients
With the Thanksgiving holiday behind us, we’re back to the grind at CIRM. Here are two exciting CIRM-funded stem cell stories that happened while you were away. Stanford Scientists Are Treating Stroke Patients with Stem Cells Smithsonian Magazine featured the work of a CIRM-funded scientist in their December Magazine issue. The article, “A Neurosurgeon’s Remarkable … Continue reading Stem Cell Stories That Caught our Eye: Stem Cell Therapies for Stroke and Duchenne Muscular Dystrophy Patients
Using heart stem cells to help boys battling a deadly disorder
It’s hard to imagine how missing just one tiny protein can have such a devastating impact on a person. But with Duchenne Muscular Dystrophy (DMD) the lack of a single protein called dystrophin has deadly consequences. Now a new study is offering hope we may be able to help people with this rare genetic … Continue reading Using heart stem cells to help boys battling a deadly disorder
Turning the corner with the FDA and NIH; CIRM creates new collaborations to advance stem cell research
This blog is part of the Month of CIRM series on the Stem Cellar A lot can change in a couple of years. Just take our relationship with the US Food and Drug Administration (FDA). When we were putting together our Strategic Plan in 2015 we did a survey of key players and stakeholders at … Continue reading Turning the corner with the FDA and NIH; CIRM creates new collaborations to advance stem cell research
CIRM’s Push for Operational Excellence
This blog is part of the Month of CIRM series CIRM adopted the mantra of “operational excellence” as a way to strengthen our problem‑solving, teamwork, and overall results. Getting better The Business Dictionary defines operational excellence as: “A philosophy of the workplace where problem-solving, teamwork, and leadership results in the ongoing improvement in an organization.” … Continue reading CIRM’s Push for Operational Excellence
The Alpha Stem Cell Clinics: Innovation for Breakthrough Stem Cell Treatments
During this third week of the Month of CIRM, we are focusing on CIRM’s Infrastructure programs which are all focused on helping to accelerate stem cell treatments to patients with unmet medical needs. So here is the question of the day: What is the world’s largest network of medical centers dedicated to providing stem cell … Continue reading The Alpha Stem Cell Clinics: Innovation for Breakthrough Stem Cell Treatments
Can Stem Cell Therapies Help ALS Patients?
A scientist’s fifteen-year journey to develop a stem cell-based therapy that could one day help ALS patients. “Can stem cells help me Clive?” The sentence appeared slowly on a computer screen, each character separated by a pause while its author searched for the next character using a device controlled by his eye muscle. The person … Continue reading Can Stem Cell Therapies Help ALS Patients?
CIRM-Funded Clinical Trials Targeting Brain and Eye Disorders
This blog is part of our Month of CIRM series, which features our Agency’s progress towards achieving our mission to accelerate stem cell treatments to patients with unmet medical needs. This week, we’re highlighting CIRM-funded clinical trials to address the growing interest in our rapidly expanding clinical portfolio. Our Agency has funded a total of … Continue reading CIRM-Funded Clinical Trials Targeting Brain and Eye Disorders
CIRM Board Appoints Dr. Maria Millan as President and CEO
Yesterday was a big day for CIRM. Our governing Board convened for its September ICOC meeting and appointed Dr. Maria Millan as our new President and CEO. Dr. Millan has been serving as the Interim President/CEO since July, replacing former President Dr. Randal Mills. Dr. Millan has been at CIRM since 2012 and was instrumental … Continue reading CIRM Board Appoints Dr. Maria Millan as President and CEO